How can polymyxin B be dosed based on current pharmacokinetic knowledge?
- PMID: 38847855
- DOI: 10.1007/s00228-024-03708-3
How can polymyxin B be dosed based on current pharmacokinetic knowledge?
Similar articles
-
Polymyxin B and haemofiltration in an adolescent with leukaemia.J Antimicrob Chemother. 2014 May;69(5):1434. doi: 10.1093/jac/dkt522. Epub 2014 Jan 8. J Antimicrob Chemother. 2014. PMID: 24402503 No abstract available.
-
Polymyxin B dosing in obese and underweight adults.Clin Infect Dis. 2013 Dec;57(12):1785. doi: 10.1093/cid/cit604. Epub 2013 Sep 18. Clin Infect Dis. 2013. PMID: 24051863 No abstract available.
-
Pharmacokinetics of polymyxin B in a patient with renal insufficiency: a case report.Clin Infect Dis. 2011 May;52(10):1280-1. doi: 10.1093/cid/cir137. Clin Infect Dis. 2011. PMID: 21507928 Free PMC article. No abstract available.
-
To B or not to B, that is the question: is it time to replace colistin with polymyxin B?Pharmacotherapy. 2015 Jan;35(1):17-21. doi: 10.1002/phar.1510. Epub 2014 Oct 24. Pharmacotherapy. 2015. PMID: 25346395 Review.
-
An update on the arsenal for multidrug-resistant Acinetobacter infections: polymyxin antibiotics.Int J Infect Dis. 2015 Jan;30:125-32. doi: 10.1016/j.ijid.2014.10.014. Epub 2014 Nov 5. Int J Infect Dis. 2015. PMID: 25461655 Review.
Cited by
-
Clinical outcomes and pharmacokinetics/pharmacodynamics of intravenous polymyxin B treatment for various site carbapenem-resistant gram-negative bacterial infections: a prospective observational multicenter study.Antimicrob Agents Chemother. 2025 Apr 2;69(4):e0185924. doi: 10.1128/aac.01859-24. Epub 2025 Mar 6. Antimicrob Agents Chemother. 2025. PMID: 40047414 Free PMC article.
References
-
- Wang X, Xiong W, Zhong M et al (2024) Pharmacokinetics of polymyxin B in different populations: a systematic review. Eur J Clin Pharmacol. https://doi.org/10.1007/s00228-024-03666-w - DOI - PubMed - PMC
-
- Wang P, Liu S, Sun T, Yang J (2024) Daily fluid intake as a novel covariate affecting the population pharmacokinetics of polymyxin B in patients with sepsis. Int J Antimicrob Agents 63:107099. https://doi.org/10.1016/j.ijantimicag.2024.107099 - DOI - PubMed
-
- Hanafin PO, Kwa A, Zavascki AP et al (2023) A population pharmacokinetic model of polymyxin B based on prospective clinical data to inform dosing in hospitalized patients. Clin Microbiol Infect 29:1174–1181. https://doi.org/10.1016/j.cmi.2023.05.018 - DOI - PubMed
-
- Liang D, Liang Z, Deng G et al (2023) Population pharmacokinetic analysis and dosing optimization of polymyxin B in critically ill patients. Front Pharmacol 14:1122310. https://doi.org/10.3389/fphar.2023.1122310 - DOI - PubMed - PMC
-
- Li X, Cheng Y, Chen B et al (2023) Population pharmacokinetics of polymyxin B in patients with liver dysfunction. Br J Clin Pharmacol 89:3561–3572. https://doi.org/10.1111/bcp.15855 - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical